AbbVie, Oracle, Apple And More On CNBC's 'Final Trades'

On CNBC's "Halftime Report Final Trades," Bryn Talkington, managing partner at Requisite Capital Management, named AbbVie (NYSE:ABBV) as her final trade with a price target of $232.